Divergent Morphologies and Common Signaling Features of Active and Inactive Oncogenic

Chenwei Wang, Shinsuke Ohnuki, Anna Savchenko, Hiroyuki Aburatani, Satoshi Yoshida, Riko Hatakeyama, Yoshikazu Ohya

Abstract read

In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chenwei WangDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan.

Shinsuke OhnukiDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan.ORCID 0000-0001-6254-081X

Anna SavchenkoDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan.

Hiroyuki AburataniGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, Japan.ORCID 0000-0003-0438-1544

Satoshi YoshidaSchool of International Liberal Studies, Nishi-Waseda Campus, Waseda University, Tokyo 169-8050, Japan.

Riko HatakeyamaInstitute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.ORCID 0000-0002-3065-6639

Yoshikazu OhyaDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan.ORCID 0000-0003-0837-1239

Funding

Biotechnology and Biological Sciences Research Council, UK BB/V016334/1Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan 22H02216

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationrhoA GTP-Binding ProteinSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionPhenotyperho GTP-Binding ProteinsrhoA GTP-Binding Proteinrho GTP-Binding ProteinsSaccharomyces cerevisiae ProteinsCalMorphcancerRHO1RHOAyeast morphology

Identifiers

PMID41002403

DOI10.3390/cells14181439

PMCPMC12468435

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.